Maximizing Exosome & EV Therapeutics Development Efficiency Through Outsourcing & Vendor Capabilities
Time: 2:00 pm
day: Pre-Conference Day
Details:
Uncover the transformative power of strategic outsourcing in advancing exosome therapeutics development. Explore how outsourcing can streamline processes, accelerate progress, and drive innovation in the field. By leveraging specialized expertise and resources, companies can overcome challenges and maximize opportunities in developing exosome-based therapies.
Delving into Funding & Investor Engagement:
• Addressing the challenge of maintaining investor interest in exosome-based therapeutics by demonstrating clinical benefits and real promise in technologies
• Mitigating risks associated with investor disengagement by ensuring that technologies show genuine clinical potential, sustaining investor confidence and support Exploring Outsourcing Considerations:
• Discussing resource constraints faced by smaller companies developing exosomebased therapeutics, leading them to outsource manufacturing, analytics, safety testing, and preclinical development
• Highlighting the benefits of outsourcing for accessing specialized expertise and facilities required for compliance with GMP standards
Evaluating Challenges Vendor Selection & Collaboration:
• Discussing the importance of selecting vendors with the necessary expertise and capabilities to provide specialized services, such as exosome isolation, characterization, and analysis, for exosome therapeutics development
• Exploring strategies for building collaborative partnerships with vendors through careful evaluation of capabilities, reliability, and alignment with project goals and timelines
